Client login

API, Chemical Development & Analytical Services / Transitioning your therapeutic peptide programme from research to clinic

Article

Back

Transitioning your therapeutic peptide programme from research to clinic

Alastair Hay walks through some of the key considerations facing the transition of peptide therapeutic programmes to clinic.

Read the full article below.

View Resource

Our Expert

Alastair Hay, Vice President of Peptides, Edinburgh, Almac API, Chemical Development & Analytical Services

Almac API, Chemical Development, Analytical & Solid State Services

Almac Sciences provides integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API).

We provide a range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.

Learn More

We offer a full suite of analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.

Our vast pool of scientific knowledge can help to overcome the analytical challenges that typically arise during drug development.

Learn More

You may also be interested in

Article

Bioalkylation Strategies to Synthesize Allylated Tetrahydroisoquinolines by Using Norcoclaurine Synthase and O-Methyltransferases

Almac Voice

The development of cutaneous limits for elemental impurities

Stay up-to-date with the latest from Almac

Join our mailing list

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies

Please complete this form to view the Article

Bioalkylation Strategies to Synthesize Allylated Tetrahydroisoquinolines by Using Norcoclaurine Synthase and O-Methyltransferases

The development of cutaneous limits for elemental impurities